Search results for "R5-920"

showing 10 items of 603 documents

CD133 expression in placenta chorioangioma presenting as a giant asymptomatic mass

2021

Background: Placental chorioangioma is the most common benign non-trophoblastic neoplasm of the placenta. Its clinical relevance lies in the size of the tumor since larger masses cause pregnancy complications, including an unfavorable neonatal outcome. Case presentation: We report the case of a 34-year-old second gravida and nullipara at the 35th week of gestation, admitted to the gynecological department for antibiotic-resistant fever. The cardiotocography performed during hospitalization showed an abnormal fetal pattern. A 2250 g newborn was delivered by cesarean section. No complications were observed during childbirth and postpartum was insignificant. On gross inspection a white fleshy …

CD31Adultmedicine.medical_specialtyMedicine (General)Placenta Diseasesgiant asymptomatic maPlacentaCase Reportgiant asymptomatic massR5-920PregnancyPlacentamedicineChildbirthCD133 expression; Giant asymptomatic mass; Placental chorioangioma; Adult; Cesarean Section; Endothelial Cells; Female; Humans; Infant Newborn; Placenta; Pregnancy; Hemangioma; Placenta Diseases; Pregnancy Complications NeoplasticHumansClinical significanceCardiotocographyGiant asymptomatic massPregnancyFetusNeoplasticplacental chorioangiomamedicine.diagnostic_testObstetricsbusiness.industryCesarean SectionCD133 expression; Giant asymptomatic mass; Placental chorioangiomaEndothelial CellsInfantGeneral Medicinemedicine.diseaseNewbornPregnancy Complicationsmedicine.anatomical_structurePlacental chorioangiomaembryonic structuresGestationFemaleGiant asymptomatic mabusinessHemangiomaCD133 expression
researchProduct

Role of genetic factors on the effect of additional loading doses and two maintenance doses used to overcome clopidogrel hyporesponsiveness.

2014

Background and objective: Additional loading doses and higher maintenance doses (MDs) have been used to overcome hyporesponsiveness of clopidogrel. We aimed to investigate whether genetic polymorphisms of two cytochromes (CYP2C19 and CYP2C9) and ABCB1 modify effect of such dose-adjustment strategy.Materials and methods: We enrolled 118 patients undergoing elective or acute percutaneous coronary intervention (PCI) with drug eluting stent (DES). Platelet reactivity index (PRI) was measured using the vasodilator-stimulated phosphoprotein (VASP) index and a cut-off value of ≥60% was defined as hyporesponsiveness. Polymorphism of two cytochromes (CYP2C19, CYP2C9) and gene ABCB1 were determined. …

CYP2C9MaleMedicine (General)ATP Binding Cassette Transporter Subfamily BTiclopidinemedicine.medical_treatmentCYP2C19PharmacologyR5-920Percutaneous Coronary InterventionmedicinePotencyHumansProspective StudiesCYP2C19AlleleCYP2C9AllelesAgedCytochrome P-450 CYP2C9Medicine(all)Polymorphism GeneticDose-Response Relationship Drugbusiness.industryClopidogrel resistanceMicrofilament ProteinsPercutaneous coronary interventionABCB1Drug-Eluting StentsVASPMiddle AgedClopidogrelPhosphoproteinsClopidogrelCytochrome P-450 CYP2C19Drug-eluting stentPharmacogeneticsAutomotive EngineeringConventional PCIFemalebusinessCell Adhesion MoleculesPlatelet Aggregation InhibitorsClopidogrel resistance; VASP; CYP2C19; ABCB1; CYP2C9medicine.drugMedicina (Kaunas, Lithuania)
researchProduct

Systemic acidemia impairs cardiac function in critically Ill patients.

2021

Background: Acidemia, is associated with reduced cardiac function in animals, but no studies showing an effect of acidemia on cardiac function in humans are reported. In the present study, we examined the effect of acidemia on cardiac function assessed with transpulmonary thermodilution technique with integrated pulse contour analysis (Pulse Contour Cardiac Output, PiCCO™) in a large cohort of critically ill patients. Methods: This was a prospective multicenter observational cross-sectional study of 297 patients from 6 intensive care units in London, England selected from all patients admitted consecutively between May 2018 and March 2019. Measurements of lowest plasma pH and concurrent ass…

Cardiac function curveCardiac outputmedicine.medical_specialtyMedicine (General)PiCCO01 natural scienceslaw.inventionABG-a03 medical and health sciences0302 clinical medicineR5-920lawIntensive careInternal medicinemedicineArterial pH030212 general & internal medicine0101 mathematicsGEFTranspulmonary thermodilutionAcidosisdPmxAcidemiaPoint-of-Care arterial blood gasbusiness.industryCritically illpH010102 general mathematicsCardiac functionGeneral MedicineCIIntensive care unitCOCritical careCardiac contractilityCardiologyCPIThermodilution techniqueSVICFImedicine.symptombusinessAcidosisResearch PaperEClinicalMedicine
researchProduct

miR-133a Enhances the Protective Capacity of Cardiac Progenitors Cells after Myocardial Infarction

2014

Summary miR-133a and miR-1 are known as muscle-specific microRNAs that are involved in cardiac development and pathophysiology. We have shown that both miR-1 and miR-133a are early and progressively upregulated during in vitro cardiac differentiation of adult cardiac progenitor cells (CPCs), but only miR-133a expression was enhanced under in vitro oxidative stress. miR-1 was demonstrated to favor differentiation of CPCs, whereas miR-133a overexpression protected CPCs against cell death, targeting, among others, the proapoptotic genes Bim and Bmf. miR-133a-CPCs clearly improved cardiac function in a rat myocardial infarction model by reducing fibrosis and hypertrophy and increasing vasculari…

Cardiac function curveProgrammed cell deathMyocardial InfarctionGene ExpressionCardiomegalyBiologyBiochemistryArticleMuscle hypertrophyParacrine signallingDownregulation and upregulationmiR-133a; Cardiac Progenitors Cells; Myocardial InfarctionFibrosisREGENERATIONmicroRNAGeneticsmedicineMyocyteAnimalsRNA MessengerOXIDATIVE STRESSlcsh:QH301-705.5ENGINEERED HEART-TISSUElcsh:R5-920Gene Expression ProfilingMICRORNAComputational BiologyCell BiologyMUSCLEmedicine.disease3. Good healthCell biologyRatsAPOPTOSISHYPERTROPHYMicroRNAsDIFFERENTIATIONlcsh:Biology (General)ImmunologyGROWTHRNA Interferencelcsh:Medicine (General)EMBRYONIC STEM-CELLSMyoblasts CardiacDevelopmental BiologyStem Cell Reports
researchProduct

On the Interaction between 1D Materials and Living Cells

2020

One-dimensional (1D) materials allow for cutting-edge applications in biology, such as single-cell bioelectronics investigations, stimulation of the cellular membrane or the cytosol, cellular capture, tissue regeneration, antibacterial action, traction force investigation, and cellular lysis among others. The extraordinary development of this research field in the last ten years has been promoted by the possibility to engineer new classes of biointerfaces that integrate 1D materials as tools to trigger reconfigurable stimuli/probes at the sub-cellular resolution, mimicking the in vivo protein fibres organization of the extracellular matrix. After a brief overview of the theoretical models r…

Cellular membraneMaterials sciencelcsh:BiotechnologyBiomedical EngineeringTheoretical modelsregenerative medicineNanotechnologyBiointerface02 engineering and technologyReviewbioelectronics010402 general chemistry01 natural sciencesRegenerative medicineBiomaterials1D materialsbiointerfacelcsh:TP248.13-248.651D materials CNTs bioelectronics biointerface photocatalysis polymers regenerative medicineMicroscale chemistrypolymerslcsh:R5-920BioelectronicsCNTs021001 nanoscience & nanotechnology0104 chemical sciencesProtein fibreslcsh:Medicine (General)0210 nano-technologyphotocatalysisMaterial chemistryJournal of Functional Biomaterials
researchProduct

A snapshot of pneumonia research activity and collaboration patterns (2001–2015): a global bibliometric analysis

2019

Background This article describes a bibliometric review of the scientific production, geographical distribution, collaboration, impact, and subject area focus of pneumonia research indexed on the Web of Science over a 15-year period. Methods We searched the Web of Science database using the Medical Subject Heading (MeSH) of “Pneumonia” from January 1, 2001 to December 31, 2015. The only document types we studied were original articles and reviews, analyzing descriptive indicators by five-year periods and the scientific production by country, adjusting for population, economic, and research-related parameters. Results A total of 22,694 references were retrieved. The number of publications in…

ChinaBiomedical ResearchSouth asiaBibliometric analysisEpidemiologyInternational CooperationPopulationHealth InformaticsBibliometricsJapanHumansChinaSocioeconomicseducationeducation.field_of_studylcsh:R5-920Mesh termScientific productionScientometricsPublicationsPneumoniaScientometricsUnited StatesEuropeGeographyMappingBibliometricslcsh:Medicine (General)Scientific productionResearch ArticleBMC Medical Research Methodology
researchProduct

High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol f…

2019

Background Noninvasive ventilation (NIV) is indicated to treat respiratory acidosis due to exacerbation of chronic obstructive pulmonary disease (COPD). Recent nonrandomized studies also demonstrated some physiological effects of high-flow nasal therapy (HFNT) in COPD patients. We designed a prospective, unblinded, multicenter, randomized controlled trial to assess the noninferiority of HFNT compared to NIV with respect to the reduction of arterial partial pressure of carbon dioxide (PaCO2) in patients with hypercapnic acute respiratory failure with mild-to-moderate respiratory acidosis. Methods We will enroll adult patients with acute hypercapnic respiratory failure, as defined by arterial…

Chronic ObstructiveTime FactorsExacerbationRespiratory ratemedicine.medical_treatmentMedicine (miscellaneous)Equivalence Trials as TopicAcute respiratory failurelaw.inventionPulmonary DiseaseHypercapnia03 medical and health sciencesPulmonary Disease Chronic ObstructiveStudy Protocol0302 clinical medicineAcute respiratory failure; Carbon dioxide; Chronic obstructive pulmonary disease; Emergency department; High-flow oxygen therapy through nasal cannula; Intensive care unit; Noninvasive ventilation; Acute Disease; Equivalence Trials as Topic; Humans; Hypercapnia; Italy; Lung; Multicenter Studies as Topic; Oxygen Inhalation Therapy; Prospective Studies; Pulmonary Disease Chronic Obstructive; Respiratory Insufficiency; Time Factors; Treatment Outcome; Noninvasive VentilationRandomized controlled triallawHigh-flow oxygen therapy through nasal cannulamedicineHumansMulticenter Studies as TopicPharmacology (medical)Intensive care unit030212 general & internal medicineProspective StudiesLungTidal volumeMechanical ventilationCOPDlcsh:R5-920business.industryEmergency departmentChronic obstructive pulmonary diseaseOxygen Inhalation Therapymedicine.diseaseIntensive care unitRespiratory acidosisTreatment OutcomeItalyCarbon dioxideAnesthesiaAcute DiseasebusinessRespiratory Insufficiencylcsh:Medicine (General)Acute respiratory failure; Carbon dioxide; Chronic obstructive pulmonary disease; Emergency department; High-flow oxygen therapy through nasal cannula; Intensive care unit; Noninvasive ventilationNoninvasive ventilation030217 neurology & neurosurgeryTrials
researchProduct

The Correlation Between Abnormal Uterine Artery Flow in the First Trimester and Genetic Thrombophilic Alteration: A Prospective Case-Controlled Pilot…

2020

Introduction. Evaluation of the first trimester uterine artery flow can predict the development of obstetrical complications. A genotype, making women prone to microthrombi. constitutes the main known susceptibility factor for anomalous development of placenta. Our aim was to study whether polymorphisms of 10 genes leading to blood clotting abnormalities are related to abnormal uterine artery blood flow in the first trimester, and may predict placenta-related diseases. Material and methods. In primary analyses we included 19 singleton pregnancies with abnormal blood flow in the uterine arteries during the first trimester of gestation, and 24 matched control with normal flow patterns. All pa…

Clinical BiochemistryPhysiology030204 cardiovascular system & hematologyArticlePreeclampsiaCorrelation03 medical and health sciences0302 clinical medicinegenetic polymorphismsPlacentamedicine.arteryGenotypemedicineUterine arterylcsh:R5-920030219 obstetrics & reproductive medicineabnormal uterine artery flowbiologybusiness.industryBlood flowmedicine.diseasemedicine.anatomical_structureMethylenetetrahydrofolate reductasebiology.proteinGestationHuman medicinebusinesslcsh:Medicine (General)Diagnostics
researchProduct

Some subgroup embeddings in finite groups: A mini review

2015

[EN] In this survey paper several subgroup embedding properties related to some types of permutability are introduced and studied. ª 2014 Production and hosting by Elsevier B.V. on behalf of Cairo University

Computer scienceMini Reviewmacromolecular substancesS-permutabilityMini reviewMathematics::Group TheoryComputingMethodologies_SYMBOLICANDALGEBRAICMANIPULATIONPermutabilityPrimitive subgroupAlgebra over a fieldFinite grouplcsh:Science (General)GeneralFinite grouplcsh:R5-920MultidisciplinaryMathematics::Combinatoricsmusculoskeletal neural and ocular physiologyAlgebranervous systemEmbeddingQuasipermutable subgrouplcsh:Medicine (General)MATEMATICA APLICADAAlgorithmSemipermutabilityMathematicsofComputing_DISCRETEMATHEMATICSlcsh:Q1-390Journal of Advanced Research
researchProduct

Continuity correction of pearson’s chi-square test in 2x2 contingency tables: A mini-review on recent development

2022

The Pearson’s chi-square test represents a nonparametric test more used in Biomedicine and Social Sciences, but it introduces an error for 2 x 2 contingency tables, when a discrete probability distribution is approximated with a continuous distribution. The first author to introduce the continuity correction of Pearson’s chi-square test has been Yates F. (1934). Unfortunately, Yates’s correction may tend to overcorrect of p-value, this can implicate an overly conservative result. Therefore many authors have introduced variants Pearson’s chi-square statistic, as alternative continuity correction to Yates’s correction. The goal of this paper is to describe the most recent continuity correctio…

Contingency tablelcsh:R5-920statisticlcsh:Public aspects of medicine2x2 contingency tableNonparametric statistics2Continuity correctionlcsh:RA1-1270Pearson’s xSettore MED/42 - Igiene Generale E ApplicataYates’s continuity correctionMini reviewTest (assessment)Settore MED/01 - Statistica Medica2x2 contingency table Pearson’s xSerra’s continuity correctionContinuity correctionStatisticsChi-square testProbability distributionlcsh:Medicine (General)Pearson’s x2 statisticStatisticMathematics
researchProduct